Streetbeat News

Analyst Ratings

ANVS

HC Wainwright & Co. has reiterated its Buy rating on Annovis Bio (NYSE:ANVS) and maintained a price target of $30.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 11:08 am

INDP

HC Wainwright & Co. has reiterated its Buy rating for Indaptus Therapeutics, maintaining a price target of $12.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 11:05 am

LEGN

HC Wainwright & Co. has reiterated its Buy rating on Legend Biotech, maintaining a price target of $73. This suggests confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 10:58 am

OCUL

HC Wainwright & Co. has reiterated its Buy rating on Ocular Therapeutix, maintaining a price target of $14. Analyst Yi Chen continues to support the stock, indicating confidence in its potential.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 10:52 am

RNAC

Needham analyst Gil Blum has reiterated a Buy rating on Cartesian Therapeutics (NASDAQ:RNAC) and maintained a price target of $41.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 10:45 am

PENG

Needham analyst Quinn Bolton maintains a Buy rating on Penguin Solutions (NASDAQ:PENG) but lowers the price target from $35 to $25.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 10:43 am

HOTH

HC Wainwright & Co. has reiterated its Buy rating on Hoth Therapeutics, maintaining a $4 price target. This suggests confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 10:38 am

URGN

HC Wainwright & Co. has maintained a Buy rating on UroGen Pharma and increased the price target from $60 to $64, indicating positive sentiment towards the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 10:35 am

MEG

Needham analyst James Ricchiuti has reiterated a Buy rating for Montrose Environmental Group (NYSE:MEG) and maintained a price target of $54.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 10:29 am

BTBT

HC Wainwright & Co. has maintained a Buy rating on Bit Digital and raised the price target from $6 to $7, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 10:26 am